Shen.AI is a deep-tech startup based in Estonia that has developed clinically validated software for vital-signs measurements. Its slogan, "Clinically validated software for vital-signs measurements," encapsulates its core focus on leveraging camera-based technology for early diagnostics and preventive medicine. The company's flagship product, Shen.AI, transforms ordinary smartphones, tablets, and computers into diagnostics tools by analyzing facial skin texture and extracting vital physiological signs in real-time.
By utilizing remote photoplethysmography (rPPG), the software is capable of measuring essential vital signs including Heart Rate, Heart Rate Variability (HRV), Respiratory Rate, Blood Pressure, and SpO2 in just 60 seconds. Additionally, it provides insights into health risks such as Stress Index, Vascular Age, and Cardiac Workload.
One of the company's key value propositions is the seamless integration of vital-signs analysis into digital products, enabling businesses to enhance their offerings and empower users to monitor their well-being comprehensively. In 2023, Shen.AI secured a €100.00K grant investment from the Cocoon Program, marking a significant milestone in its journey to revolutionize the intersection of healthcare and technology within the Insurtech industry.
No recent news or press coverage available for Shen.AI.